On December 11, 2025, TOWN HEALTH (03886) collaborated with Pfizer Hong Kong to advance public respiratory health education. Through the TOWN HEALTH Charity Fund, the company donated a batch of 20-valent pneumococcal conjugate vaccines (manufactured by Pfizer) to vulnerable communities served by Tung Wah Group of Hospitals, fostering community health protection through medical-social collaboration.
TOWN HEALTH and Pfizer Hong Kong actively responded to the Hong Kong government’s "Primary Healthcare Blueprint," jointly launching a respiratory health education initiative to shift public health awareness from "treatment-focused" to "prevention-first." Additionally, TOWN HEALTH will leverage its extensive network of medical centers across Hong Kong to improve public access to the 20-valent pneumococcal conjugate vaccine.
Tung Wah Group of Hospitals, as a key community partner, will oversee the proper allocation of the donated vaccines to eligible beneficiaries within its service units. The collaboration aims to reduce disease burdens among vulnerable groups and enhance overall community health.
Mr. Chua Ka Tsan, GBS, JP, Chairman and CEO of TOWN HEALTH, emphasized the threat of pneumococcal infections to public health, particularly among the elderly and disadvantaged populations. He highlighted the importance of the 20-valent vaccine, which provides broad protection against 20 serotypes in a single dose. The donation reflects TOWN HEALTH’s commitment to supporting vulnerable communities.
Mr. Raymond Chan, Head of Primary Care Business and Operations at Pfizer Hong Kong and Macau, noted the healthcare burden posed by pneumococcal diseases and stressed the need for comprehensive serotype protection. The partnership aims to raise public awareness and improve prevention efforts.
Dr. Li Chen, Director of Tung Wah Group’s Tam Kam Biu Lee Wai Kiu Medical Centre (North Point), expressed gratitude for the contributions from TOWN HEALTH and Pfizer Hong Kong, pledging efficient vaccine distribution to those in need.
Dr. Ku Sung Wai, Deputy Medical Director of TOWN HEALTH, cited the latest Department of Health statistics, revealing pneumonia as Hong Kong’s second-leading cause of death in 2024, claiming over 11,000 lives. Vaccination remains the most effective preventive measure against pneumococcal diseases, which can lead to severe conditions like invasive pneumonia, bacteremia, and meningitis.
Respiratory specialist Dr. Wong Kam Cheung warned of the rapid transmission and overlapping symptoms of pneumococcal infections with influenza, increasing diagnostic challenges. While antibiotics are the primary treatment, rising resistance underscores the critical role of vaccination in reducing invasive infections and complications, including heart attack risks in high-risk individuals. He reiterated that "prevention is better than cure" in combating pneumococcal threats.